Topics
Meeting category
Date(s)
4 Apr 2025 - 5 Apr 2025
Location
Barcelona,
Spain
Meeting type
Hybrid Meeting
15th International Workshop on Women & HIV 2025
General
Thank you!
Key Take Away Messages
The 15th International Workshop on Women & HIV took place in a hybrid format on 4-5 April 2025 in Barcelona, Spain.
- The rates of HIV infection in women continue to increase, and the numbers are impacted by migration, extreme weather events, resource insecurities, and program interruptions.
- Breastfeeding policies for women living with HIV continue to evolve, and strategies to enable women to breastfeed safely are evolving.
- Women living with HIV are at increased risk of cardiovascular disease, and the risk models designed for persons without HIV infection do not always apply. Statins have been shown to decrease cardiovascular events, especially in those over 40 years and with other risk factors.
- Injectable antiretroviral agents for treatment and prevention are adding an important choice for women living with and at risk for HIV. Challenges regarding access need to be addressed.
- Management of women with HIV needs to extend beyond antiretroviral therapy to include coinfection (HPV) and co-morbidities (liver disease and cognitive function).
- We need to continue to ensure women are aware of the value of clinical trials and how their contribution advances the field
The 16th International Workshop on Women & HIV 2026 will take place on 10-11 April 2026 in Europe (TBC).
About this Program
The International Workshop on Women & HIV has now completed its 15th year and continues to evolve. It is an outstanding opportunity for healthcare providers, researchers, government, industry, and community representatives to discuss, debate, and further their knowledge on the issues related to HIV and women.
The format of the workshop enables attendees to learn from world-leading HIV experts and discuss the issues, gaps, and opportunities for further learning and research. Many of the attendees continue to participate each year and have formed valuable relationships and partnerships that have led to collaborative projects.
The enthusiasm and dedication of the participants is palpable throughout the workshop. The debates and roundtables are an important vehicle to discuss the issues and challenge dogmas.
Over the years, the number and quality of submitted abstracts have continued to improve. The workshop also provides a forum for early-career investigators to present their work and to personally meet with experts they view as mentors and inspirations for their work. The workshop considers both local and global issues and the information learnt in one setting is often translated into another.
We encourage you to consider joining us in 2026!
On behalf of the Organizing Committee
Workshop Chair
Local Chairs
General Information
Uniques Features
- Two-day hybrid meeting
- Invited lectures from international experts
- Interactive roundtable sessions
- Ample time for discussion
- Invited lectures from international experts
- Interactive roundtable sessions
- Ample time for discussion
Who Should Attend?
- HIV clinicians
- Researchers
- OBGYNs
- Government and NGO representatives
- Industry representatives
- Community advocates
- Pharmacists
- Medical Students
- Other healthcare providers involved in daily care of women living with HIV
- Researchers
- OBGYNs
- Government and NGO representatives
- Industry representatives
- Community advocates
- Pharmacists
- Medical Students
- Other healthcare providers involved in daily care of women living with HIV
Meeting Objectives
This meeting aimed to:
- Facilitate an unbiased and scientific knowledge exchange regarding HIV & Women, and encourage early-career investigators to actively partake in the workshop;
- Summarize and promote the current state of the science regarding HIV & Women, and its successful translation and dissemination; and
- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers and women to improve knowledge sharing, with the end goal of improving the quality of life of women living with HIV.
- Facilitate an unbiased and scientific knowledge exchange regarding HIV & Women, and encourage early-career investigators to actively partake in the workshop;
- Summarize and promote the current state of the science regarding HIV & Women, and its successful translation and dissemination; and
- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers and women to improve knowledge sharing, with the end goal of improving the quality of life of women living with HIV.
Practical Information
Venue
The workshop took place in the Novotel Barcelona City.
The address is:
Novotel Barcelona City
Avenida Diagonal,
Carrer de la Ciutat de Granada,
201, Entrada Por,
08018 Barcelona, Spain
Distance from Josep Tarradellas Barcelona-El Prat Airport (BCN): 17 km
The address is:
Novotel Barcelona City
Avenida Diagonal,
Carrer de la Ciutat de Granada,
201, Entrada Por,
08018 Barcelona, Spain
Distance from Josep Tarradellas Barcelona-El Prat Airport (BCN): 17 km
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the workshop was English.
Enduring Materials
Enduring materials will be available shortly after the conclusion of the workshop, provided the permission from speakers.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Please note that payment by credit card is required to be able to register for the workshop. Please contact the conference secretariat if this is not possible for you.
Registration is open!
Fees and Conditions
|
Regular Delegates- |
Regular Delegates- |
Industry* - In-Person |
Industry* - Virtual |
|
|---|---|---|---|---|
|
Early Fee (payment on/before 11 September 2024) |
€495.00 |
€395.00 |
€695.00 |
€595.00 |
|
Regular Fee (payment on/before 4 February 2025) |
€695.00 |
€595.00 |
€895.00 |
€795.00 |
|
Late Fee (payment from 5 February 2025) |
€795.00 |
€695.00 |
€995.00 |
€895.00 |
| Discounts | |
|---|---|
| Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITH accepted abstract | 50% Off Early Fee |
| Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITHOUT accepted abstract | 50% Off Current Regular Fee |
| NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates | 50% Off Current Regular Fee |
| Members of Endorsers | 25% Off Current Regular Fee |
|
Sponsors |
Contact Secretariat |
*Countries included in the low-income and middle-income economies list of the World Bank Classification
Important
-
We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
Registration Fee Includes
For Onsite Attendees:
- Access to all scientific sessions, including poster area
- Workshop pack, including abstract book and program
- Refreshments during the coffee breaks
- Buffet lunch on meeting days
For Virtual Attendees Only:
- Access to all scientific sessions
- Digital workshop pack, including the program book
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Access to all scientific sessions, including poster area
- Workshop pack, including abstract book and program
- Refreshments during the coffee breaks
- Buffet lunch on meeting days
For Virtual Attendees Only:
- Access to all scientific sessions
- Digital workshop pack, including the program book
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please contact the workshop secretariat to use the Group Registration Portal.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to offer 50% discount on the Early Fee to early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract, and a 50% discount on the current registration fee without an accepted abstract.
IMPORTANT: Registration fees waivers are offered to the presenting author only.
To be eligible as an early-career investigator, you should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
IMPORTANT: Registration fees waivers are offered to the presenting author only.
To be eligible as an early-career investigator, you should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Sponsored Attendee
If you are invited by a pharmaceutical or diagnostic company, or if your registration is organized by a travel agency, please do not register online. The sponsoring company will be asked to register you via the conference secretariat.
Payment
By credit card only: online or by written authorization (see online registration).
Cancellation Policy
In case of cancellation, the following refunds are applicable:
- Cancellation before/on 4 March 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 4 March 2025: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 28 March 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
- Cancellation before/on 4 March 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 4 March 2025: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 28 March 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference secretariat needs to receive:
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2025 embargo policy.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2025 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Program
The presentation videos and slides for speakers’ lectures will be made available, provided that they have granted us permission to do so.
Friday, 4 April 2025
Opening & Welcome - 08:30
08:30
Opening & Welcome
Session 1: HIV Epidemic in Women: Where Do We Stand? -
Barbara Bartmeyer, DVM PhD
Session Chairs:
08:45
Global and European Epidemiology & Current Trends in Transmission Routes
HIV/AIDS, STI Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
09:05
#1 Conceptualizing Climate-Informed HIV Prevention: Associations between Extreme Weather Events and Resource Insecurities with HIV Vulnerabilities among Climate-Affected Adolescent Girls and Young Women in Nairobi and Kisumu, Kenya
Carmen Logie
Canada
09:20
#2 Five-Year Trends in Characteristics and Care of Women Diagnosed with HIV during Pregnancy in England, 2018 to 2022
Rebecca Sconza
United Kingdom
09:35
Q&A
09:55
Coffee Break
Session 2: Pregnancy & Breastfeeding -
Session Chairs:
10:25
Controversy and Consensus in Pregnancy and Infant Feeding Guidelines
10:45
#3 Breastfeeding in Women Living with HIV: A South East London Clinic’s 9 Years’ Experience
Emily Mabonga
United Kingdom
11:00
#4 Tele-Lactation as a Tool for Equitable HIV Care: An Examination of Lactation Consultant HIV Knowledge, HIV-Related Stigma, Tele-Lactation Experience, and Willingness to Support Breastfeeding/Chestfeeding People with HIV in North America
Emily Anne Barr
United States
11:15
#5 The Well Project Survey Reveals Dramatic Shift in Provider Support of Breast/Chestfeeding After 2023 HIV Guideline Updates
Ciarra Covin & Krista Martel
United States
11:30
#6 Unravelling the Pharmacokinetic Mechanism Explaining Lower Bictegravir Exposure during Pregnancy
Lena Christina Wendy Van Der Wekken-Pas
The Netherlands
11:45
Panel Discussion: Breastfeeding Choices
12:15 Industry-Supported Symposium - Innovating for her: Addressing the unmet needs of women - 11:40 - 13:00
13:00
Lunch Break
Session 3: Debate - STATIN Preventive Therapy to Reduce Cardiovascular Risks in Women Living with HIV -
Moderator:
14:00
Opening Words
14:05
Voting
14:10
Healthcare Provider: For the Proposition
14:17
Healthcare Provider: Against the Proposition
14:24
Community Representative: For the Proposition
14:28
Community Representative: Against the Proposition
14:32
Discussion with the Audience
14:52
Rebuttal
14:56
Voting
15:00
Results & Closing
15:05
Coffee Break
Session 4: New Landscape of PrEP -
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Session Chairs:
15:35
PrEPping for Women: Looking Forward
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
15:55
PrEP Implementation During the Refugee Crisis
16:15
#7 Pre-Exposure Prophylaxis Among a Cohort of Cis and Transgender Female Sex Workers in Buenos Aires, Argentina: Not All Women Are the Same
Valeria Irene Fink
Argentina
16:30
#8 A Game Changer: Acceptability of Long-Acting Injectable PrEP (Cabotegravir) Among Female Sex Workers and Men Who Have Sex with Men in Nakonde District, Zambia
Lubinda Chingumbe
Zambia
16:45
Q&A
17:05
Welcome Reception & Guided Poster Tours (4 Parallel Sessions)
Guided Poster Tour 1: HPV, Cervical Cancer and Screening
Moderator:
Dr. Sharon Walmsley
#18 Systematic Review and Meta-Analysis of Human Papilloma Virus Prevalence and Genotype Disparity among HIV Infected Women in Africa
Amare Yirga Wondu, Hungary
#19 Strengthening HIV and Cervical Cancer Prevention through Community Engagement in Tanzania: Community-Led Monitoring (CLM) as Mechanism to Understand Gender Inequality and Address Barriers That Women Face in Accessing Comprehensive Healthcare
Alia Amimi, Morocco
#49 Exploring Socioeconomic Inequalities in Cervical Cancer Screening Among Women Living with HIV Across Five Low- and Middle-Income Countries (LMICs)
Jonathan Nkalubo, Uganda
#74 Optimising cervical cancer screening for Women living with HIV: Gains and experiences in three years of implementation in Southern Nigeria
Olufemi Ibitoye, Nigeria
Guided Poster Tour 2: ART
Moderator:
Dr. William Short
#22 Associations between Maternal Hormones and Birth Anthropometrics Differ between ARV Classes
Lena Serghides, Canada
#23 Women With HIV Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF): 24-Month Effectiveness, Safety, and Patient-Reported Outcomes (PROs) From the Prospective Observational BICSTaR Study
Hila Elinav, Israel
#24 Perinatal and Early Infant Outcomes after Bictegravir Exposure in Pregnancy: A Canadian Surveillance Study
Jeffrey Man Hay Wong, Canada
#25 The RISE Infant Feeding Framework: A Conceptual Multi-Level Approach to Understanding Infant Feeding Among People with HIV in Higher-Income Countries
Emily Anne Barr, United States
#26 Doravirine in Breastmilk of Healthy, Lactating, Hiv-Negative Women after a Single Dose of 100mg
Lena Christina Wendy Van Der Wekken-Pas, The Netherlands
#27 Perinatal and Neonatal Outcomes after 1st vs. 2nd Generation INSTI Use in Pregnancy
Rosa Balleny, Canada
Guided Poster Tour 3: Challenges
Moderator:
Dr. Mariana Mărdărescu
#28 Navigating Futures: The Vital Role of Integrating a Comprehensive Family Planning Approach for Adolescent Girls and Young Women on the DREAMS Initiative in Kapiri Mposhi District, Central Zambia
Kangwa Kasonde, Zambia
#29 Is Housing Instability Linked to Poor Health Outcomes in Women Living in the US?
Maeve Brin, United States
#32 Unveiling an Overlooked Population: Climacteric Symptom Prevalence in Women with HIV in Mexico City
Angelina Silva-Casarrubias, Mexico
#33 Current Practice of Healthcare Professionals When Screening for and Managing Low Bone Mineral Density in Women Living with HIV in the UK
Hajra Okhai, United Kingdom
#46 Viral Load Situation after 12 Months of ARV Treatment in Women Living with HIV in Decentralized Areas of Guinea in 2023 Thanks to the Multiplication of Genexpert Devices
Balla Beavogui, Guinée
Guided Poster Tour 4: Mental Health
Moderator:
Dr. Carmen Logie
#34 The Intersection of Viral Load Categories and Depression Among Women Living with HIV: A Focus on Mental Health Disparities
Jonathan Lukusa Tshimwanga, Namibia
#35 Suicidality and Crisis: A Longitudinal Exploration of Suicidality in Adolescent Mothers Living with and Affected by HIV in South Africa
Kathryn Steventon Roberts, United Kingdom
#48 Reduced Adherence to Antiretroviral Therapy in Pregnant Women Living with HIV with Intimate Partner Violence in the United States
Florence Momplaisir, United States/Peru
#52 Improving Research Accessibility and Inclusion: Language Translation of Research and Knowledge Mobilization Materials by, with and for English-as-an-Additional Language (EAL) Immigrant Women Living with HIV
Melanie Murray, Canada
18:05
End of Day 1
Saturday, 5 April
Day 2 Opening - 08:30
08:30
Day 2 Opening
Session 5: HIV Across Lifespan -
Session Chairs:
08:40
Bridging the Gap: Comprehensive Approaches to HIV and HPV in Women's Health Care
09:00
Women from the Romanian Cohort – Study Findings: A Unique Experience in Europe
09:20
#9 Concordance Between ASCVD and PREVENT Cardiovascular Risk Models in Women Living With and Without HIV
Tetiana Povshedna
Canada
09:35
#10 Non-HIV Chronic/Latent Viral Infections Are Associated with Markers of Inflammation in Males but Not Females Living with HIV and Not Living with HIV
Renying Cai
Canada
09:50
#11 Sleep Quality among Women Living with HIV by Reproductive Stage in the United States-Based Hope Study
Rusul Al-Ani
United States
10:05
#12 History of Abnormal Ovarian Function Not Associated with Fibrosis-4 Index among Women Living with or without HIV in British Columbia, Canada
Monika M Kowatsch
Canada
10:20
Q&A
10:40
Coffee Break
Session 6: Beyond Undetectable -
Maria Luisa Montes Ramirez, MD, PhD
Session Chairs:
11:20
Managing Non-Communicable Diseases in Women Aging with HIV: Brain Health
11:40
Managing Non-Communicable Diseases in Women Aging with HIV: MASLD
HIV Unit, Internal Medicine Department, La Paz University Hospital, IdiPAZ, CIBERINFEC, Madrid, Spain
12:00
#14 A Novel Approach to Weight Loss: Bringing SatPro into the HIV Clinic
Eleanor Hamlyn
United Kingdom
12:15
Q&A
12:40
Lunch Break
European AIDS Treatment Group Symposium - Inclusion of Women and Transgender People in Clinical Trials: Advancing Equity in Research - 13:40
13:40
Welcome and Introduction
13:45
Beyond Barriers: Addressing the Exclusion of Trans People in Non-HIV Clinical Trials and Their Unmet Health Needs
Amanita Calderon-Cifuentes
HIV Research and Advocacy Office TGEU, Germany
14:00
Insights from the Research Perspective on Diversifying Clinical Trials
Beatriz Mothe Pujadas
HIV Unit - Infectious Disease Department IrsiCaixa, Spain
14:15
Discussing Advocacy Efforts to Include Underrepresented Groups in Research - The Belong Initiative
14:30
Q&A and Conclusions of Symposium
Session 7: Long-Acting Antiretrovirals for Women -
Ana González-Cordón, MD, PhD
Session Chairs:
14:40
Goodbye Daily Pills: Long-Acting HIV Treatment for Women – The Evidence
15:00
Real-World Data: Challenges on Implementation of LA-ART
Hospital Clínic of Barcelona, IDIBAPS, CIBERINFEC, University of Barcelona, Spain
15:20
#15 Clinical Outcomes among Women Receiving CAB+RPV LA in the OPERA Cohort: Subgroup Differences Based on Race, BMI, and Age
Jessica Altamirano
United States
15:35
#16 Real-World Efficacy and Tolerability of Long-Acting Cabotegravir/Rilpivirine in Older Woman with Polypharmacy and Comorbidities
María Jesús Pérez Elías
Spain
15:50
Discussion: Future Perspectives: Priorities for Women
16:20
Closing Remarks
16:30
End of Workshop
Committees
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
The members of the Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
- Karoline Aebi-Popp, PD, MD, MSc, University Hospital Bern, Switzerland
- Sergii Antoniak, MD, Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Sciences of Ukraine, Ukraine
- Dawn Averitt, The Well Project/WRI, United States
- Olga Belyaeva, Eurasian Network of People who Use Drugs (ENPUD), Ukraine
- Marina Bobkova, MD, PhD, Gamaleya Center for Epidemiology and Microbiology, Russian Ministry of Health, Russia
- Claudia Cortes, MD, University of Chile, Chile
- Dazon Dixon Diallo, MPH, Sister Love, United States
- Mirjam-Colette Kempf, MD, MPH, University of Alabama at Birmingham, United States
- Justyna Kowalska, MD, PhD, Hospital for Infectious Diseases, Poland
- Allen Kyendikuwa, BA, Uganda Youth Coalition on Adolescent SRHR and HIV (CYSRA), Uganda
- Mona Loutfy, MD, FRCPC, MPH, Women's College Research Institute (Univ. Toronto), Canada
- Mariana Mardarescu, MD, PhD, National Institute for Infectious Diseases "Prof. Dr. Matei Bals", Romania
- Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
- Deborah Money, MD, FRCSC, University of British Columbia, Canada
- Teresia Otieno, ATHENA Network, United States
- Lena Serghides, PhD, University Health Network, Canada
- William R. Short, MD, MPH, FIDSA, University of Pennsylvania, United States
- Shema Tariq, PhD, FRCP, University College London, United Kingdom
- Patricia Vasquez, MD, Hospital San Juan de Dios, Chile
- Marta Vasylyev, MD, Astar Medical Center, Ukraine
- Markella Zanni, MD, MGH/Harvard Medical School, United States
Support
Gold Level
Silver Level
Scholarship Supporter
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in the International Workshop on Women & HIV 2025.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Lara da Silva Miguel at Lara@amededu.com.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgment on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level
Symposium
Innovating for her: Addressing the unmet needs of women
This satellite symposium was presented by:
ViiV Healthcare
Program | 4 April 2025 -
Ana González-Cordón, MD, PhD
Session Chair:
12:15 CEST
Why Are Women Being Left Behind?
Panel Discussion Moderator:
12:20 CEST
Panel discussion
Hospital Clínic of Barcelona, IDIBAPS, CIBERINFEC, University of Barcelona, Spain
12:45 CEST
Q&A
12:55 CEST
How do We Ensure We Leave No Women Behind?
12:58 CET
Call to action
13:00 CEST
End of Symposium
Endorsers
Endorsers
Previous Editions
Previous Editions
- 14th Edition - International Workshop on HIV & Women 2024, United States (Hybrid)
- 13th Edition - International Workshop on HIV & Women 2023, United States (Hybrid)
- 12th Edition - International Workshop on HIV & Women 2022, Virtual
- 11th Edition - International Workshop on HIV & Women 2021, Virtual
- 10th Edition - International Workshop on HIV & Women 2020, United States
- 9th Edition - International Workshop on HIV & Women 2019, United States
Accreditation
Accreditation Statement
The International Workshop on Women & HIV 2025, Barcelona, Spain 04/04/2025 - 05/04/2025 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10.5 European CME credits (ECMEC®s).
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Language
Related Programs
